Company Filing History:
Years Active: 2005-2010
Title: Katalin Urbán-Szabó: Innovator in Pharmaceutical Chemistry
Introduction
Katalin Urbán-Szabó is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzymes and receptors.
Latest Patents
Katalin holds 3 patents that showcase her innovative work. Her latest patents include compounds that are heterocyclic amides useful as inhibitors of the dipeptylpeptidase-IV (DPP-IV) enzyme. This invention also details the process for the preparation of these compounds and their intermediates. Another notable patent involves imidazoquinoline derivatives, which serve as adenosine A3 ligands. This invention relates to the general formula of these ligands, including their salts, solvates, and isomers, as well as their pharmaceutical applications.
Career Highlights
Katalin is currently employed at Sanofi-Aventis, a leading global biopharmaceutical company. Her work at Sanofi-Aventis has allowed her to focus on innovative drug development, contributing to advancements in therapeutic options for various medical conditions.
Collaborations
Throughout her career, Katalin has collaborated with notable colleagues, including László Balázs and Sándor Bátori. These collaborations have further enriched her research and development efforts in the pharmaceutical sector.
Conclusion
Katalin Urbán-Szabó is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. Her contributions continue to impact the field positively, showcasing her dedication to advancing medical science.